In New Brunswick, Horizon Health Network and Amgen Canada have agreed to work on establishing a new pathway that will see therapy made available to patients much faster than through conventional processes. The agreement will provide the Regional Health Authority with direct access to therapy, running parallel to the existing process, while dramatically reducing the amount of time the patient needs to wait for access to innovative treatment.
Innovative partnership will deliver expedited access to cancer treatment for New Brunswick patients
Previous
Previous
Canada’s Health Researchers Suggest Key Panel Report as Summer Reading for MPs
Next
Next

